Impact of the nitric oxide-donor pentaerythrityl-tetranitrate on perinatal outcome in risk pregnancies: a prospective, randomized, double-blinded trial

References

[1] Akolekar R, Syngelaki A, Sarquis R, Zvanca M, Nicolaides KH. Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11-13 weeks. Prenat Diagn. 2011;31:66–74.10.1002/pd.2660Search in Google Scholar

[2] Askie LM, Duley L, Henderson-Smart DJ, Stewart LA. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet. 2007;369:1791–8.10.1016/S0140-6736(07)60712-0Search in Google Scholar

[3] Bujold E, Morency AM, Roberge S, Lacasse Y, Forest JC, Giguere Y. Acetylsalicylic acid for the prevention of preeclampsia and intra-uterine growth restriction in women with abnormal uterine artery Doppler: a systematic review and meta-analysis. J Obstet Gynaecol Can. 2009;31:818–26.10.1016/S1701-2163(16)34300-6Search in Google Scholar

[4] Bujold E, Roberge S, Lacasse Y, Bureau M, Audibert F, Marcoux S, et al. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol. 2010;116:402–14.10.1097/AOG.0b013e3181e9322aSearch in Google Scholar PubMed

[5] Cantwell R, Clutton-Brock T, Cooper G, Dawson A, Drife J, Garrod D, et al. Saving Mothers’ Lives: reviewing maternal deaths to make motherhood safer: 2006-2008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. Br J Obstet Gynaecol. 2011;118:1–203.Search in Google Scholar

[6] Chang J, Elam-Evans LD, Berg CJ, Herndon J, Flowers L, Seed KA, et al. Pregnancy-related mortality surveillance–United States, 1991–1999. MMWR Surveill Summ. 2003;52:1–8.Search in Google Scholar

[7] Cnossen JS, Morris RK, ter Riet G, Mol BW, van der Post JA, Coomarasamy A, et al. Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis. Can Med Assoc J. 2008;178:701–11.10.1503/cmaj.070430Search in Google Scholar PubMed PubMed Central

[8] Daiber A, Gori T. Vascular tolerance to nitroglycerin in ascorbate deficiency: results are in favour of an important role of oxidative stress in nitrate tolerance. Cardiovasc Res. 2008;79:722–3.10.1093/cvr/cvn174Search in Google Scholar PubMed

[9] Daiber A, Wenzel P, Oelze M, Munzel T. New insights into bioactivation of organic nitrates, nitrate tolerance and cross-tolerance. Clin Res Cardiol. 2008;97:12–20.10.1007/s00392-007-0588-7Search in Google Scholar PubMed

[10] Dodd JM, McLeod A, Windrim RC, Kingdom J. Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction. Cochrane Database Syst Rev. 2010;(6): CD006780. DOI: 10.1002/14651858.CD006780.pub2.10.1002/14651858.CD006780.pub2Search in Google Scholar PubMed

[11] Dragoni S, Gori T, Lisi M, Di Stolfo G, Pautz A, Kleinert H, et al. Pentaerythrityl tetranitrate and nitroglycerin, but not isosorbide mononitrate, prevent endothelial dysfunction induced by ischemia and reperfusion. Arterioscler Thromb Vasc Biol. 2007;27:1955–9.10.1161/ATVBAHA.107.149278Search in Google Scholar PubMed

[12] Froen JF, Gardosi JO, Thurmann A, Francis A, Stray-Pedersen B. Restricted fetal growth in sudden intrauterine unexplained death. Acta Obstet Gynecol Scand. 2004;83:801–7.Search in Google Scholar

[13] Gardosi J, Francis A. Adverse pregnancy outcome and association with small for gestational age birthweight by customized and population-based percentiles. Am J Obstet Gynecol. 2009;201:e21–8.10.1016/j.ajog.2009.04.034Search in Google Scholar PubMed

[14] Huppertz B, Burton G, Cross JC, Kingdom JC. Placental morphology: from molecule to mother – a dedication to Peter Kaufmann – a review. Placenta. 2006;27:S3–8.10.1016/j.placenta.2006.01.007Search in Google Scholar

[15] Kahler C, Schleussner E, Moller A, Seewald HJ. Nitric oxide donors: effects on fetoplacental blood flow. Eur J Gynaecol Obstet Reprod Biol. 2004;115:10–4.10.1016/S0301-2115(02)00429-3Search in Google Scholar

[16] Klemmensen A, Tabor A, Osterdal ML, Knudsen VK, Halldorsson TI, Mikkelsen TB, et al. Intake of vitamin C and E in pregnancy and risk of pre-eclampsia: prospective study among 57 346 women. Br J Obstet Gynaecol. 2009;116:964–74.10.1111/j.1471-0528.2009.02150.xSearch in Google Scholar

[17] Lees C, Langford E, Brown AS, de Belder A, Pickles A, Martin JF, et al. The effects of S-nitrosoglutathione on platelet activation, hypertension, and uterine and fetal Doppler in severe preeclampsia. Obstet Gynecol. 1996;88:14–19.10.1016/0029-7844(96)00070-1Search in Google Scholar

[18] Lees C, Valensise H, Black R, Harrington K, Byiers S, Romanini C, et al. The efficacy and fetal-maternal cardiovascular effects of transdermal glyceryl trinitrate in the prophylaxis of pre-eclampsia and its complications: a randomized double-blind placebo-controlled trial. Ultrasound Obstet Gynecol. 1998;12:334–8.10.1046/j.1469-0705.1998.12050334.xSearch in Google Scholar PubMed

[19] Mandruzzato G, Antsaklis A, Botet F, Chervenak FA, Figueras F, Grunebaum A, et al. Intrauterine restriction (IUGR). J Perinat Med. 2008;36:277–81.10.1515/JPM.2008.050Search in Google Scholar PubMed

[20] Meher S, Duley L. Nitric oxide for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev. 2007;(2):CD006490.10.1002/14651858.CD006490Search in Google Scholar PubMed PubMed Central

[21] Poon LC, Volpe N, Muto B, Yu CK, Syngelaki A, Nicolaides KH. Second-trimester uterine artery Doppler in the prediction of stillbirths. Fetal Diagn Ther. 2013;33:28–35.10.1159/000342109Search in Google Scholar PubMed

[22] Quinn MJ Jr, Crouse LC, McFarland CA, LaFiandra EM, Johnson MS. Reproductive and developmental effects and physical and chemical properties of pentaerythritol tetranitrate (PETN) in the rat. Birth Defects Res B Dev Reprod Toxicol. 2009;86:65–71.10.1002/bdrb.20184Search in Google Scholar PubMed

[23] Rey E, Garneau P, David M, Gauthier R, Leduc L, Michon N, et al. Dalteparin for the prevention of recurrence of placental-mediated complications of pregnancy in women without thrombophilia: a pilot randomized controlled trial. J Thromb Haemost. 2009;7:58–64.10.1111/j.1538-7836.2008.03230.xSearch in Google Scholar PubMed

[24] Richardus JH, Graafmans WC, Verloove-Vanhorick SP, Mackenbach JP. Differences in perinatal mortality and suboptimal care between 10 European regions: results of an international audit. Br J Obstet Gynaecol. 2003;110:97–105.10.1046/j.1471-0528.2003.02053.xSearch in Google Scholar

[25] Roberge S, Nicolaides K, Demers S, Villa P, Bujold E. Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: a meta-analysis. Ultrasound Obstet Gynecol. 2013;41:491–9.10.1002/uog.12421Search in Google Scholar PubMed

[26] Roberts JM, Myatt L, Spong CY, Thom EA, Hauth JC, Leveno KJ, et al. Vitamins C and E to prevent complications of pregnancy-associated hypertension. N Engl J Med. 2010;362:1282–91.10.1056/NEJMoa0908056Search in Google Scholar PubMed PubMed Central

[27] Rodger M, Hague W, Kingdom J, for the TIPPS Investigators. The Thrombophilia in Pregnancy Prophylaxis Study (TIPPS): a multi-national randomized trial of dalteparin versus no dalteparin to prevent pregnancy complications in pregnant thrombophilic women. J Thromb Haemost. 2013;11:78.Search in Google Scholar

[28] Steiner H, Schneider KTM. Dopplersonographie in Gynäkologie und Geburtshilfe, A4 Referenzkurven. Heidelberg: Springer Medizin Verlag;2008:2. Auflage, 326–7.Search in Google Scholar

[29] Thangaratinam S, Langenveld J, Mol BW, Khan KS. Prediction and primary prevention of pre-eclampsia. Best Pract Res Clin Obstet Gynaecol. 2011;25:419–33.10.1016/j.bpobgyn.2011.02.008Search in Google Scholar PubMed

[30] Valensise H, Vasapollo B, Novelli GP, Giorgi G, Verallo P, Galante A, et al. Maternal and fetal hemodynamic effects induced by nitric oxide donors and plasma volume expansion in pregnancies with gestational hypertension complicated by intrauterine growth restriction with absent end-diastolic flow in the umbilical artery. Ultrasound Obstet Gynecol. 2008;31:55–64.10.1002/uog.5234Search in Google Scholar PubMed

[31] Villar J, Purwar M, Merialdi M, Zavaleta N, Thi Nhu Ngoc N, Anthony J, et al. World Health Organisation multicentre randomised trial of supplementation with vitamins C and E among pregnant women at high risk for pre-eclampsia in populations of low nutritional status from developing countries. Br J Obstet Gynaecol. 2009;116:780–8.10.1111/j.1471-0528.2009.02158.xSearch in Google Scholar PubMed

[32] Voigt M, Schneider KT, Jahrig K. Analysis of a 1992 birth sample in Germany. 1: new percentile values of the body weight of newborn infants. Geburtshilfe Frauenheilkd 1996;56:550–8.10.1055/s-2007-1023283Search in Google Scholar PubMed

[33] Xu H, Perez-Cuevas R, Xiong X, Reyes H, Roy C, Julien P, et al. An international trial of antioxidants in the prevention of preeclampsia (INTAPP). Am J Obstet Gynecol. 2010;202: e231–9.10.1016/j.ajog.2010.01.050Search in Google Scholar PubMed